Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of Lazertinib as Consolidation Therapy in Patients With Locally Advanced, Unresectable, EGFR-Mutant Non-Small Cell Lung Cancer (Stage III) Following Chemoradiation Therapy

Sung Yong Lee · 2022
ClinicalTrials.gov · Datasets · License: Public Domain · 2022
Open Source ↗
egfrnsclc
non-small cell lung cancer stage iii, egfr positive non-small cell lung cancer, non-squamous non-small-cell lung cancer, nsclc, non-squamous cell carcinoma, egfr, egfr-tki, lazertinib, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 898594
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.